Safirstein Metcalf LLP announces that a class action has been filed on behalf of those who purchased securities of Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) between May 15, 2017 and June 5, 2018, both dates inclusive (the “Class Period”). If you...
The post Akers Biosciences, Inc. Class Action Has Been Filed appeared first on Safirstein Metcalf LLP 1-800-221-0015.
source https://www.safirsteinmetcalf.com/akers-biosciences/
No comments:
Post a Comment